Publications 2021 - Journal papers (9)
- LIFEx-texture: Wu, YJ., Liu, YC., Liao, CY. et al. A comparative study to evaluate CT-based semantic and radiomic features in preoperative diagnosis of invasive pulmonary adenocarcinomas manifesting as subsolid nodules. Sci Rep 11, 66 (2021) (doi)
- LIFEx-MTV: Hotta, M., Minamimoto, R., Toyohara, J. et al. Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CT. Eur J Nucl Med Mol Imaging (2021) (doi)
- LIFEx-texture: Yoo, S., Kang, S., Yoon, J. et al. Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy. Sci Rep 11, 296 (2021) (doi)
- LIFEx-MTV: Hotta, M., Minamimoto, R., Toyohara, J. et al. Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CT. Eur J Nucl Med Mol Imaging (2021) (doi)
- LIFEx-texture: Nicolas Aide, Nicolas Elie, Cécile Blanc-Fournier, Christelle Levy, Thibault Salomon and Charline Lasnon ; Hormonal Receptor Immunochemistry Heterogeneity and 18F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers ; Front. Oncol., 12 January 2021 (doi)
- LIFEx-MTV: Prigent, K., Lasnon, C., Ezine, E. et al. Assessing immune organs on 18F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients. Eur J Nucl Med Mol Imaging (2021) (doi)
- LIFEx-texture: Li, Y., Zhang, Y., Fang, Q. et al. Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. Eur J Nucl Med Mol Imaging (2021) (doi)
- LIFEx-texture: Sheen, H., Kim, J.S., Lee, J.K. et al. A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion. Abdom Radiol (2021) (doi)
- LIFEx-texture: Sheen, H., Kim, J.S., Lee, J.K. et al A radiomics nomogram for predicting transcatheter arterial chemoembolization refractoriness of hepatocellular carcinoma without extrahepatic metastasis or macrovascular invasion. Abdom Radiol (2021). (doi)